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Abstract
Objective To assess the accuracy of malaria diagnosis and treatment
at primary level clinics in Afghanistan.
Design Prospective observational study.
Setting 22 clinics in two Afghan provinces, one in the north (adjoining
Tajikistan) and one in the east (adjoining Pakistan); areas with seasonal
transmission of Plasmodium vivax and Plasmodium falciparum.
Participants 2357 patients of all ages enrolled if clinicians suspected
malaria.
Interventions Established (>5 years) microscopy (12 clinics in east
Afghanistan), newly established microscopy (five clinics in north
Afghanistan), and no laboratory (five clinics in north Afghanistan). All
clinics used the national malaria treatment guidelines.
Main outcome measures Proportion of patients positive and negative
for malaria who received a malaria drug; sensitivity and specificity of
clinic based diagnosis; prescriber’s response to the result of the clinic
slide; and proportion of patients positive and negative for malaria who
were prescribed antibiotics. Outcomes were measured against a double
read reference blood slide.
Results In health centres using clinical diagnosis, although 413 of 414
patients were negative by the reference slide, 412 (99%) received a
malaria drug and 47 (11%) received an antibiotic. In clinics using new
microscopy, 37% (75/202) of patients who were negative by the reference
slide received a malaria drug and 60% (103/202) received an antibiotic.
In clinics using established microscopy, 50.8% (645/1269) of patients
who were negative by the reference slide received a malaria drug and
27.0% (342/1269) received an antibiotic. Among the patients who tested
positive for malaria, 94% (443/472) correctly received a malaria drug
but only 1 of 6 cases of falciparum malaria was detected and
appropriately treated. The specificity of established and newmicroscopy
was 72.9% and 79.9%, respectively. In response to negative clinic slide
results, malaria drugs were prescribed to 270/905 (28.8%) and 32/154
(21%) and antibiotics to 347/930 (37.3%) and 99/154 (64%) patients in
established and new microscopy arms, respectively. Nurses were less
likely to misprescribe than doctors.
Conclusions Despite a much lower incidence of malaria in Afghanistan
than in Africa, fever was substantially misdiagnosed as malaria in this
south Asian setting. Inaccuracy was attributable to false positive
laboratory diagnoses of malaria and the clinicians’ disregard of negative
slide results. Rare but potentially fatal cases of falciparum malaria were
not detected, emphasising the potential role of rapid diagnostic tests.
Microscopy increased the proportion of patients treated with antibiotics
producing a trade-off between overtreatment with malaria drugs and
probable overtreatment with antibiotics.
Introduction
Malaria remains one of the most important infectious diseases
of poverty. Accurate diagnosis of the disease is essential for
both targeting malaria drugs to those who need them and
identifying those with alternative (often serious) non-malarial
causes of infection. Consequently the use of malaria parasite
based diagnostic tests using microscopy or rapid diagnostic tests
lies at the heart of the World Health Organization’s new global
guidelines for the treatment of malaria.1 Clinical diagnosis of
malaria, based on symptoms alone, is known to be inaccurate2-4
so diagnosis based on detection of parasites has clear advantages.
In Africa, however, there is now clear evidence that
overdiagnosis of malaria and misprescription of malaria
treatment to patients who are negative for parasites is a
widespread problem. As a consequence, serious non-malarial
infections are missed,5-9 drugs are wasted, and the cost
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effectiveness of the diagnostic tests is reduced.10 11 In south and
central Asia, where programmes to expand access to malaria
diagnosis are currently underway, this problem has been much
less considered. This omission may be based on the assumption
that no problem exists in south and central Asia, where the
incidence of malaria is much lower and is responsible for a
smaller proportion of febrile cases than in Africa. In south and
central Asia, it has often been perceived that the greater risk is
that cases of malaria are being missed rather than that malaria
is being overdiagnosed and overtreated. Although the incidence
of malaria in south and central Asia may be low compared with
Africa, the population at risk is larger,12 13 so the potential overall
burden for public health if the misdiagnosis seen in Africa is
also seen in south Asia is of considerable public health
importance. The absence of data on overdiagnosis of malaria
in this part of Asia is therefore an important gap, and any
assumption that problems found in Africa are not relevant to
Asia is probably fallacious and certainly needs substantiating.
In most of south and central Asia malaria is predominantly
caused by Plasmodium vivax, but Plasmodium falciparum is
also seen.13 This presents distinct operational challenges,
different fromAfrica and South East Asia where most or almost
all malaria is caused by P falciparum and transmission is
generally more intense: firstly, among the causes of fever,
malaria is in the minority so needs to be differentiated from
non-malarial fevers, and, secondly, the rarer and more
pathogenic P falciparum needs to be differentiated from P vivax
to allow proper targeting of artemisinin combination therapy.
Overdiagnosis of malaria results in other potentially serious
infections being overlooked, such as pneumonia and invasive
bacterial disease.14-16 Although mortality from vivax malaria in
South East Asia is more common than previously thought,17 18
it is low compared with falciparum malaria or other bacterial
causes of febrile illness, so the risk to the patient if malaria is
missed is lower than in areas dominated by falciparummalaria.
Missing a serious non-malarial infection because of
overtreatment of malaria is therefore a greater threat to people
and likely to be more wasteful of resources in this setting than
in Africa. Microscopy is the standard method of parasite based
malaria diagnosis.19 At the periphery of stable countries and in
crisis affected areas, however, most people do not have access
to accurate parasitological diagnosis and treatment is largely
based on clinical signs and symptoms.
Since so few data are available from south or central Asia we
undertook an observational study to determine the accuracy of
diagnosis and targeting of treatment in 22 clinics at primary
healthcare level. The clinics were in malaria endemic areas of
Afghanistan where either clinical or microscopic diagnosis of
malaria was routinely applied and where falciparum and vivax
malaria coexist.
Afghanistan is an important setting to deal with the problem of
overdiagnosis and mistreatment of malaria. It is situated in the
WHOEasternMediterranean Region, which has designs on the
elimination of malaria as a medium to long term goal; it borders
theWHO-European Region area, which aims to be malaria free
by 2015; acute febrile illnesses are a major cause of morbidity
and mortality; case management is a major public health
problem; and resources are scarce. The health services of the
country are being rebuilt and coverage of services expanded,
so evidence that improves policy and practice is important at
this stage of Afghanistan’s development to prevent entrenchment
of poor practice.
Methods
Study area, health system, and sites
The study was carried out in two Afghan provinces, one in the
north (adjoining Tajikistan) and one in the east (adjoining
Pakistan). In both provinces malaria is a minor cause of febrile
illness. In the north, low transmission results in a slide positivity
rate of less than 1%, whereas in the east transmission is more
intense and the slide positivity rate reaches 10-30%. P vivax is
the predominant species, accounting for 80-90% of malaria
cases annually; the remainder being caused by P falciparum.
Transmission is seasonal, limited by altitude and temperature,
with falciparum malaria occurring in late summer and autumn
and vivax malaria in spring and summer.19-21 Malaria control,
focused on the distribution of insecticide treated nets amid
improving post-conflict healthcare coverage, has succeeded in
reducing transmission in Afghanistan so malaria is now less
common than it was 5-10 years before this study took place.
The health system in which the study took place has a well
defined hierarchical structure (the Basic Package of Health
Services) and has been a priority of post-conflict development,
implemented by non-governmental organisations.22 The Basic
Health Centres and Comprehensive Health Centres in the study
are the primary points of access for free outpatient services.
The health system structure is comparable in each province but
differs in the availability of malaria diagnosis. In the eastern
region most health facilities have microscopy, which was
established 10-20 years ago. In the northern region microscopy
had not been established before 2009, but during the study five
laboratories were established by the national programme and
equipped with microscopy. This allowed the comparison of
targeting diagnostic accuracy and treatment in three contrasting
operational settings. In the north (low transmission of malaria),
five clinics used clinical diagnosis (with no laboratory support)
and five had newly established microscopy (August 2009),
whereas in the east (high transmission of malaria) all 12 clinics
had been using microscopy for at least five years (table 1⇓).
In routine care the treatment of malaria is based on the national
malaria treatment guidelines. Under the guidelines a combination
of chloroquine and sulfadoxine-pyrimethamine is used to treat
clinically diagnosed malaria (termed suspected malaria in the
guidelines), chloroquine is used to treat laboratory confirmed
vivax malaria (termed confirmed vivax), and artemisinin
combination therapy (sulfadoxine-pyrimethamine with
artesunate) is used to treat laboratory confirmed uncomplicated
falciparum malaria (termed confirmed falciparum). The
guidelines do not provide instruction on treatment or further
examination of patients with a negative diagnosis.
Consultations are carried out by trained doctors or, in their
absence, by nurses or midwives. In this study we describe any
health workers who carried out consultations with and prescribed
medicine to patients as clinicians.
The selection of health centre was based on location; we
considered basic health centre and community health centre
clinics eligible if they were located in secure areas, accessible
to study staff, and did not routinely refer patients to an external
laboratory for diagnosis. Based on these criteria, we excluded
36 clinics in the study provinces. Overall, 10 clinics were
selected in the north and 12 in the east (table 1).
Patient enrolment
Trained study staff (registrars) screened patients who presented
at the clinics with non-specific self reported fever. These patients
were then evaluated by the clinician against the inclusion and
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exclusion criteria. Inclusion criteria were any patient where the
clinician considered malaria in the diagnosis (either prescribing
a malaria drug or requesting a diagnosis, or would request a
diagnosis if it were available) and the patient (or parent or
guardian) gave informed consent. Exclusion criteria were
patients with a diagnostic result from another clinic, those who
the clinician referred to another facility for diagnosis, and those
in a critical condition or requiring urgent treatment. Eligible
patients were invited to give written informed consent and
enrolled.
Data collection
Clinic data were recorded on proforma patient tracking forms.
After enrolment the study registrar noted the patient’s personal
details and the clinician recorded the patient’s signs and
symptoms, the final diagnosis (based on clinical signs or the
results of the slide), and the treatment prescribed.
In clinics where microscopic diagnosis was available, the
clinician was given the result of the clinic slide (read by the
clinic microscopist) in 30-60 minutes and the result was noted
on the form. The information on the form included the species,
parasite stages, and, if carried out, parasite counts. This process
matched (and was part of) the normal operations in the clinics.
Data were double entered using Microsoft Access 2007
(Microsoft, Seattle, WA).
Study outcomes
We compared the operational effectiveness of the three
diagnostic interventions in providing accurate diagnosis and
treatment of malaria. The primary outcome was the proportion
of patients with suspected malaria who were accurately treated
for malaria. This proportion was defined as patients who were
positive for malaria parasites by reference slide and received
an appropriate malaria drug and patients who were negative by
reference slide and did not receive a malaria drug and were
therefore independent of the slide positivity rate.
Secondary outcomes were the accuracy of clinic based
microscopy compared with the reference slides, the proportion
of patients with positive and negative results for malaria by
clinic slide who were prescribed a malaria drug, the proportion
of patients with negative results by clinic slide who received an
antibiotic, and the proportion of patients positive for P
falciparum who received artesunate combination therapy.
Statistical analysis
Enrolment in 2009 covered the period from June to September,
when the transmission seasons for P vivax and P falciparum
concur. The sample size calculation was based on a slide
positivity rate of 20% (not met owing to the decreasing
prevalence of malaria in febrile patients) and aimed for a target
of 1980 patients per arm. We used logistic regression analysis
to identify associations between preselected explanatory
variables: diagnostic type, positive or negative reference slide
result for malaria, sex, age group, status of clinician (doctor v
nurse or midwife), clinic type (Comprehensive Health Centre
or Basic Health Centre), and the primary outcome of accurate
treatment. We made no additional correction for clustering.
Diagnostic accuracy was measured using the standard measures
of sensitivity and specificity. Data were analysed using Stata
v11.
Sample collection and laboratory methods
Blood slides were collected at all sites. In health centres with
no microscopy, trained study registrars prepared slides onsite
for reading at the reference laboratory. In health centres with
microscopy, the microscopist prepared routine slides for the
clinic diagnosis and collected a second slide for storage as a
reference slide.
Both thick and thin smears were prepared. These were air dried,
fixed with methanol, and stained with 10%Giemsa solution for
30 minutes. The clinic microscopist read the clinic slides and
fed back results to the clinician. The clinic microscopists
received no additional training before the study.
The clinic microscopist (study registrar if in a clinic using
clinical diagnosis) prepared and fixed the reference slide before
storage. The expert microscopist in either the north or east
stained these slides for a first read within three days of being
fixed. The slides were then transported to Kabul for a second
(and third) reading. The expert microscopists double read the
reference slides at 150× magnification, blinded to each other’s
results and to that of the clinic slide (if taken). A slide was
declared negative if no parasites were seen after examination
of 100 fields. If a slide was positive, a parasite count was carried
out and quantified against 200 white blood cells. If the diagnosis
of the twomicroscopists differed, a third microscopist examined
the slide and a best of three rule was applied.
Results
A total of 2381 patients were enrolled in the study from 1 July
to 19 September 2009 (figure⇓). Table 2⇓ shows the
characteristics of the sample. Data from 24 (1.0%) patients were
not evaluable because of missing reference slides or failure to
record the final diagnosis or treatment.
Few patients in the north had malaria according to the reference
slide result: only one of 415 (0.2%) in the clinical diagnosis
arm and none of 202 in the new microscopy arm (table 3,⇓
figure). More patients had malaria in the east: 471 of 1740
(27.1%) were positive for malaria—six (1%) of the 471 positive
cases had falciparum infection and 465 (99%) had vivax
infection. One of these cases was coinfected with falciparum
and vivax malaria.
Primary outcome analysis
In health centres in the north that used clinical diagnosis, only
1% (3/415) of patients were accurately treated for fever (table
3). In health centres in the north that used new microscopy,
treatment accuracy was 63% (127/202) and in health centres in
the east where microscopy was established, treatment accuracy
was 60.7% (1056/1740, χ2=0.4, P=0.5).
Most patients who were classified as inaccurately treated (97%)
had been prescribed a malaria drug but had a negative reference
slide result. Among the 414 whowere clinically diagnosed, 412
(99%) had a negative reference slide result but were treated with
a malaria drug (table 3, figure). In the new microscopy setting,
this proportion was 37% (75/202) compared with 50.8%
(645/1269) in the established microscopy setting (χ2=51.5,
P<0.001).
The logistic regression analysis showed that diagnosis by
microscopy was the main factor associated with accurate
treatment of patients suspected of having malaria (table 4⇓).
Other factors associated with accurate treatment were being
treated by a midwife or nurse rather than a doctor and being
treated in a community health centre rather than a basic health
centre. Children aged 6-10 years were less likely to be accurately
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treated than other age groups (adjusted odds ratio 0.6, 95%
confidence interval 0.4 to 0.8; P<0.001). Those treated in the
centres with new microscopy were more likely to be accurately
treated than those in the centres with established microscopy
(2.2, 1.5 to 3.2; P<0.001).
Accuracy of clinic microscopy
Both clinic based microscopy settings had a low specificity. In
the clinics in the north with newmicroscopy, there were 39/193
(20%) false positive results, giving a specificity of 79.8% (table
5⇓). In the clinics in the east with established microscopy, there
were 329/1212 (27.1%) false positive results (χ2=2.8, P=0.1).
In the higher endemic eastern area, where more malaria cases
were recorded, there were 47/451 (10%) false negative results,
giving a sensitivity of 89.6% and a specificity of 72.9%. Clinical
diagnosis in the low transmission setting had a specificity of
0.2%, with 412/413 (99%) false positive results.
Clinicians’ response to diagnosis
Among the health centres with microscopy, a blood slide was
produced in the clinic for most patients (95.6%). In the new
microscopy arm, malaria treatment was given to 37/39 (95%)
patients with a positive clinic slide result compared with 732/733
(99.9%) in the established microscopy arm (Fisher’s exact
P=0.007). Overall, 21% (32/154) of patients with a negative
clinic slide result were treated with a malaria drug in the new
microscopy arm compared with 270/905 (28.8%) in the
established microscopy arm (χ2=5.3, P=0.02).
Doctors in the established microscopy arm were more likely to
prescribe a malaria drug in the presence of a negative clinic
slide result than were nurses or midwives (254/795, 31.9% v
16/140, 11%; Fisher’s exact test: P<0.001) (table 6⇓), although
the type of patient (age, sex) did not differ. This trend was less
evident in the new microscopy arm (25/109 23% v 7/45 16%;
Fisher’s exact test: P=0.3) (table 6). For patients with a positive
clinic slide result, nurses andmidwives prescribedmalaria drugs
with near 100% accuracy.
Prescription of artemisinin combination
therapy for falciparum malaria
Reference slides were positive for P falciparum for six patients,
giving a slide positivity rate in the east of 0.3% (6/1740). Only
one slide was correctly identified by the clinic microscopist as
containing P falciparum and the patient was treated with
artemisinin combination therapy. Of the four undiagnosed cases
of falciparum monoinfection, two were diagnosed as negative
and two were diagnosed as containing vivax by clinic
microscopy. The two patients who were wrongly diagnosed as
having vivax malaria were given chloroquine, one of those
declared negative was given sulfadoxine-pyrimethamine with
chloroquine (the recommended treatment for suspected malaria)
and the other received no malaria drug.
Clinic microscopists identified 14 cases of falciparum malaria.
Compared with the reference slide, nine of these were negative,
four had P vivax, and one had P falciparum. Of these 14 patients,
three were treated with chloroquine and six with
sulfadoxine-pyrimethamine, one was indeterminate, and four
were prescribed doses of artemisinin combination therapy
(sulfadoxine-pyrimethamine with artesunate). One dose of
artemisinin combination therapy was correctly given to the
patient with accurately detected falciparummalaria and to three
patients with clinic slides that were false positive for falciparum
malaria (two were negative and one was positive for vivax
malaria by the reference slide).
Prescription of antibiotics
Antibiotics were prescribed to 20.8% (362/1740) of patients
with suspectedmalaria in the clinics with establishedmicroscopy
and 60% (103/202) in the clinics with newmicroscopy (χ2=90.6,
P<0.001). The percentage of patients receiving antibiotics was
lower (11%, 47/414) in the clinical diagnosis arm compared
with established microscopy arm (χ2=19.4, P<0.001).
In response to negative clinic slide results clinicians prescribed
antibiotics to 64% (99/154) of patients in the new microscopy
arm and 37.3% (347/930) in the established microscopy arm
(χ2=302; P<0.001). By comparison, 270/905 (28.8%) of patients
with a negative clinic slide result received a malaria drug in the
establishedmicroscopy arm (χ2=11.5 P=0.001). Antibiotics were
less frequently prescribed to patients with positive clinic slide
results than negative in both microscopy arms but there were
more prescriptions for cotreatment with antibiotics and malaria
drugs in the new microscopy arm than in the established
microscopy arm (8% (3/29) v 1.9% (14/733), respectively,
χ2=5.7; P=0.02).
Of 512 prescriptions of antibiotics, the most frequently
prescribed were amoxicillin (181, 20.5%), penicillin (127, 24%),
cotrimoxazole (105, 20.5%), chloramphenicol (30, 6%),
doxycycline (13, 2.5%), and ciprofloxacin (5, 1%). Tonsillitis
followed by urinary tract infections were the most common
alternative diagnoses given by the clinicians for patients with
a negative test result.
Variation between clinics
The accuracy of treatment varied significantly between
microscopy clinics. In the new microscopy arm, the accuracy
of treatment ranged from 7% to 86.2%. In the established
microscopy arm, the accuracy of treatment in basic health
centres ranged from 37% to 68% and in community health
centres from 51.3% to 91.5%. Among the clinics with clinical
diagnosis, accuracy was uniformly poor (<1%).
Discussion
Our study shows that in this south Asian setting of low incidence
of malaria, almost all of which is the relatively less serious vivax
form, malaria is substantially overdiagnosed as a cause of
infection and results in large numbers of patients with other
causes of acute febrile illness being mistreated. The few cases
of falciparum malaria seen in this epidemiological setting were
mostly not detected and consequently were not treated with
artemisinin combination therapy. Because malaria is much less
common and predominantly due to Plasmodium vivax,
overtreatment of malaria presents a worse risk-benefit outcome
to patients than it would in Africa, or some areas of South East
Asia where a higher proportion of febrile illness is due to malaria
and is mostly caused by the potentially fatal Plasmodium
falciparum.
Diagnosis and drug targeting
Compared with clinical diagnosis, microscopy improves the
targeting of malaria drugs, but only by half, and it increases the
prescription of antibiotics. Problems with both the quality of
microscopy and the prescribers’ response to the diagnostic result,
equally contribute to a cumulative 40-50% loss of accuracy in
treatment for malaria. Microscopy in both epidemiological
settings produced a high proportion of false positive diagnoses
and, as in Africa8 23-25 and a single centre study from India,16
clinicians often disregarded negative diagnostic results and
provided malaria treatment. Comparison between new and
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established microscopy suggests that the problem occurs in both
entrenched and new microscopy services in the primary health
system. Since the population at risk of malaria in the south and
central regions of Asia is larger than that in Africa,12 13 and acute
infection remains a major part of avoidable mortality and
morbidity, the public health implications are important.
Although most patients with malaria received a malaria drug,
targeting of artemisinin combination therapy to those with
confirmed falciparum malaria was poor. This was chiefly
because of inaccurate microscopy resulting in undetected
infections and false positive results. This shows the challenge
of accurately identifying rare cases of falciparum malaria in a
transmission area where vivax malaria is predominant. Even
when clinicians were given a clinic slide result (rightly or
wrongly) mentioned as containing falciparum, less than 30%
of the affected patients were treated with artemisinin
combination therapy, suggesting that targeting would be poor
even if microscopy was accurate.
Antibiotic prescription was more common where microscopy
rather than clinical diagnosis was used and was more common
among patients with a negative clinic slide result than positive.
Even so, patients with a negative clinic slide result were almost
as likely to be treated with a malaria drug as with an antibiotic
and, overall, patients with a negative reference slide result were
nearly twice as likely to receive amalaria drug than an antibiotic.
In low transmission areas where clinical diagnosis was used,
the chances of malaria were less than 1%, but prescription of
antibiotics was infrequent and almost all patients were treated
with malaria drugs. Although data on the causes of non-malarial
fever in Afghanistan is scant,26 most cases may be viral and self
limiting (although bacterial causes cannot be ruled out27), might
respond to antibiotics, and are undoubtedly being missed. In
Tanzania and Kenya, for example, around 10% of children
admitted to a hospital had pathogenic bacteria detected, most
being non-typhi salmonella and pneumococcus14 15 in patients
who were both positive and negative for malaria, but in the same
sites under 2% of outpatients who were negative for malaria
and almost no outpatients who were positive for malaria had
bacteraemia.28-30 Patterns of bacterial sepsis are different between
Africa and Asia (for example, typhoid is significantly more
common in south Asia) so it is not possible to say whether the
increase in antibiotic prescription seen here represents
over-prescription or better targeting of antibiotics. The choice
of antibiotics by clinicians would, however, not be ideal for
covering Gram negative sepsis. Antibiotics are over prescribed
in most healthcare settings, and from a public health perspective
the improved treatment of malaria may be offset by the negative
effects of overtreatment with antibiotics. This will be resolved
by studies with reliable bacteriology (not currently available in
this low resource setting).
Improved targeting
The question of how to treat patients when test results are
negative is a common dilemma for clinicians in malaria endemic
countries.5 In studies in east and west Africa,7 8 31 32 the decision
to treat patients who have negative test results with malaria
drugs is borne out of several factors: an inflated perception of
malaria risk compared with the real level of transmission, the
lack of alternative treatments for febrile illness, and low
confidence in negative slide results.31 32 Guidelines themselves
contribute to the problem by adopting a precautionary principle
or appearing ambiguous in their definition of “confirmed” and
“suspected” or “clinical” malaria.31-33 Adherence to negative
diagnostic test results differs significantly between doctors and
nursing staff even though both groups of practitioners use the
same guidelines. This leads to highly variable quality of service
from clinic to clinic, reinforcing the role of quality assurance,
unambiguous guidelines, and standardised clinical training.
Improving and sustaining coverage of quality microscopy
services is challenging in under-resourced health systems.34 In
areas of low transmission, detection of the relatively rare cases
of malaria among febrile patients is crucial for sustaining control
and progression to elimination because systematic overdiagnosis
exaggerates the real burden of malaria. Rapid diagnostic tests
for malaria are now being widely deployed and if their accuracy
and quality can be maintained under routine conditions they
may improve diagnostic accuracy at the clinic level.35 25
However, if the deployment is not accompanied by changes in
treatment practice by clinicians, then rapid diagnostic tests will
not reach their full potential. Evaluation of the impact of such
tests on differential diagnosis and treatment of vivax and
falciparummalaria from non-malarial fevers in south and central
Asia should be a priority, and improving the standards of
existing microscopy requires more investment.
Limitations and applicability to other areas
This study has the limitations of any observational study. There
is potential for a Hawthorne effect—where clinicians’ behaviour
may be altered by observation. If applicable here, this effect
would probably result in an improved performance and an
underestimate of the scale of the problem. Although new
microscopy was introduced into the northern region of
Afghanistan by the national malaria control programme (and
not the investigators) during the study, it was a non-random
introduction and in view of this and due to other differences
between the microscopy settings (for example, intensity of
transmission) we have been cautious in the interpretation of
differences between new and established microscopy.
Our findings are likely to be applicable to other areas of
Afghanistan. As the study area and health system were not
unlike much of malaria endemic Afghanistan, we consider it
likely to be representative of practice in the country as a whole.
Despite Afghanistan’s well documented poverty and chronic
conflict, healthcare reconstruction has received impressive
investment and political support and is run by contracted
non-governmental organisations on a performance basis.36 In
most of south and central Asia, by comparison, public health
systems are often equally or more impoverished but have not
received the same levels of investment as their Afghan
counterparts so, contrary to many people’s assumptions, this
part of Afghanistan may have better health services than other
areas of south and central Asia that serve impoverished
communities (services for urban higher socioeconomic groups
are often better and provided privately, but this group is less
likely to get malaria). Overdiagnosis was also common in the
Indian study from a relatively well resourced (single) health
centre.16 Until widespread misdiagnosis and treatment has been
corroborated in other countries it is impossible to be sure that
it is representative of south and central Asia in general, but our
view is that it is safer to assume that it is and to take robust steps
to identify and tackle what is likely to be a major public health
challenge.
Conclusion
Despite the low incidence of vivaxmalaria in Afghanistan, there
is consistent, substantial overdiagnosis of non-malarial fevers
as malaria, falciparum malaria is poorly targeted with
artemisinin combination therapy, and severe bacterial illnesses
are probably being overlooked. When parasite based diagnosis
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is used, a reduction in overtreatment with malaria drugs is
achieved but this gain may come at the cost of over-prescription
of antibiotics. Since acute infections are such a large part of the
burden of avoidable mortality and morbidity and the population
of affected areas so large, this is a major public health problem.
Improvements in the quality and coverage of diagnosis, evidence
based guidelines for the diagnosis of other causes of febrile
illness, and provision of alternative evidence based treatments
for patients with negative test results for malaria are required.
However, efforts to improve diagnostic coverage and accuracy
will be undermined without concurrent interventions to change
understanding, behaviour, and practice among clinicians.
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What is already known on this topic
Global guidelines for malaria recommend treatment with malaria drugs only when a diagnostic test positively identifies malaria parasites
in the patient’s blood
In African settings, however, many patients are treated for malaria even when the diagnostic test result is negative
The extent of this problem is relatively unknown in south and central Asia where more than two billion people live in areas at risk of
malaria
What this study adds
Overdiagnosis and mistreatment of patients negative for malaria is widespread in this part of Asia
Misdiagnosis and treatment is caused by inaccurate microscopy and the clinicians’ tendency to treat with malaria drugs even when a
test result is negative
Falciparum malaria is poorly targeted with effective drugs, and other potentially fatal causes of fever are missed even when a parasite
based diagnosis is available
Tables
Table 1| Description of clinics included in study, showing clinic type and diagnostic approach, by Afghan province
TotalEastNorthCharacteristics
HighLowTransmission of parasites
No of clinics:
15510Basic Health Centres
770Comprehensive Health Centres
Diagnostic method:
10010*Clinical
505*New microscopy
12120Established microscopy
454958053043Average No of attendees registered during study period, per clinic
*Five clinics introduced microscopy in August 2009, part way through the study.
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Table 2| Characteristics of patients at enrolment according to type of diagnosis and Afghan province. Values are numbers (percentages)
of patients unless stated otherwise
East: established microscopy (n=1750)
North
Characteristics New microscopy (n=213)Clinical diagnosis (n=418)
No enrolled:
958——Comprehensive Health Centres
792213418Basic Health Centres
784 (44.8)89 (42)147 (35)% male
13.5 (11.1)22.9 (15)23.6 (14)Mean (SD) age (years)
Age group:
355 (20.3)17 (8)27 (6)0-5
614 (35.1)24 (11)32 (8)6-10
250 (14.3)36 (17)71 (17)11-15
247 (14.1)45 (21)102 (24)16-20
241 (13.8)69 (32)138 (33)21-40
43 (2.5)22 (10)47 (11)>40
Clinician providing treatment:
1528 (87.3)147 (69)376 (90)Doctor
222 (12.7)66 (31)42 (10)Nurse or midwife
Average No (range) of patients enrolled at each clinic:
137 (70-213)——Comprehensive Health Centres
95 (29-209)43 (11-65)42 (25-76)Basic Health Centres
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Table 3| Number and proportion of patients with suspected malaria who were accurately treated with malaria drugs measured against
result of reference blood slide. Values are number affected/total number in group (percentage) unless stated otherwise
East: established microscopy
North
Variables New microscopyClinical diagnosis
471/1740 (27.1)0/2021/415 (0.2)Reference slide positive for malaria
Parasites detected in reference slide:
465 (98.7)—1Plasmodium vivax
6 (1.2)—0Plasmodium falciparum
1 (0.2)*—0Coinfection with P vivax and P falciparum
Treated correctly:
1056/1740 (60.7)127/202 (63)3/415 (1)According to reference slide result
1383/1663 (83.2)159/193 (82)—According to clinic slide result
Treatment
Malaria status:
645/1269 (50.8)75/202 (37)412/414 (99)Negative, given malaria drugs
29/471 (6.2)—0Positive, not given correct malaria drugs
Positive test result:
1/6(16.7)——P falciparum, treated with SP plus AS
432/465 (92.9)—1 (100)P vivax, treated with CQ†
0——Mixed infection, treated with SP plus AS
Negative test result:
3/1740 (0.2)——P falciparum, treated with SP plus AS
630/1274 (49.4)72/202 (36)408/414 (99)P vivax, treated with CQ†
222/1269 (17.5)21/202 (10)139/414 (34)Malaria, treated with SP plus CQ
Antibiotics prescribed:
20/471 (4.3)—0Positive for malaria
342/1269 (27.0)103/202 (60)47/414 (11)Negative for malaria
SP=sulfadoxine-pyrimethamine; AS=artesunate; CQ=chloroquine.
*Patient also included and evaluated as being positive for P vivax and P falciparum, separately.
†Including patients treated with SP plus CQ.
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Table 4| Univariate and multivariate analysis of factors associated with accurate treatment with malaria drugs in patients with suspected
malaria. Values are number accurately treated/number in group (percentage) unless stated otherwise
P valueAdjusted odds ratio (95% CI)P valueOdds ratio (95% CI)Accurately treatedVariables
Diagnostic method*:
113/412 (0.7)Clinical
<0.001229 (71 to 743)<0.001232 (72 to 750)127/202 (62.9)New microscopy
<0.001102 (32.3 to 323)<0.001212 (68 to 664)1056/1739 (60.7)Established microscopy
Diagnosis*:
11433/471 (91.9)Malaria
<0.0010.07 (0.05 to 0.1)<0.0010.06 (0.04 to 0.08)753/1885 (40.0)Not malaria
Patients’ sex†:
11546/1099 (54.1)Male
1.01.0 (0.8 to 1.2)0.0020.8 (0.7 to 0.9)640/1347 (47.5)Female
Age group*:
11250/396 (63.1)0-5
<0.0010.6 (0.4 to 0.8)0.0030.7 (0.5 to 0.9)358/666 (53.8)6-10
0.60.9 (0.6 to 1.3)<0.0010.6 (0.4 to 0.8)176/352 (50.0)11-15
0.61.1 (0.8 to 1.6)<0.0010.5 (0.4 to 0.6)177/390 (45.4)16-20
0.61.1 (0.8 to 1.6)<0.0010.4 (0.3 to 0.6)188/440 (42.7)21-40
0.30.8 (0.4 to 1.4)<0.0010.3 (0.2 to 0.4)37/112 (33.0)>40
Clinician providing treatment*:
11979/2034 (48.1)Doctor
<0.0012.1 (1.6 to 2.9)<0.0011.9 (1.5 to 2.5)207/322 (64.3)Nurse or midwife
Clinic type*:
11531/1405 (37.8)Basic Health Centre
<0.0012.4 (1.9 to 2.9)<0.0013.6 (3.1 to 4.3)655/951 (68.9)Comprehensive Health Centre
*χ2, P<0.001.
†χ2, P=0.01-001.
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Table 5| Accuracy of clinic level diagnosis compared with double or triple read reference slides. Values are number/number in group
(percentage) unless stated otherwise
Clinician in north*East: established microscopyNorth: new microscopyVariables
412/413 (99.8)329/1212 (27.1)39/193 (20.2)†False positive result
0/147/451 (10.4)—False negative result
10089.6 (88.1 to 91.1)—Sensitivity, % (95% CI)
0.2 (0 to 0.7)72.9 (70.7 to 75.0)79.8 (73.4 to 85.2)Specificity, % (95% CI)
0.2 (0 to 0.7)55.1 (52.7 to 57.5)—Positive predictive value
10095.0 (93.9 to 96.0)—Negative predictive value
*Against clinicians diagnosis based on signs and symptoms alone.
†New compared with established microscopy: Fisher’s exact, P=0.02.
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Table 6| Accuracy of clinicians’ prescription of malaria drugs against clinic slide results, stratified by status of prescriber. Values are
number/number in group (percentage) unless stated otherwise
Nurses or midwivesDoctors
Variables East: established microscopyNorth: new microscopyEast: established microscopyNorth: new microscopy
16/140 (11.4)7/45 (15.6)254/795 (31.9)*25/109 (22.9)*Negative result, treated (false positive)
0/750/121/658 (0.2)2/27 (7.4)Positive result, not treated (false negative)
10010099.9 (99.7 to 100)92.6 (88.2 to 97.0)Sensitivity, % (95% CI)
88.6 (84.3 to 92.8)84.4 (75.0 to 93.9)66.7 (64.3 to 69.1)77.1 (70.0 to 84.1)Specificity, % (95% CI)
*Doctors compared with nurses: in north Fisher’s exact, P=0.3; in east Fisher’s exact, P<0.001.
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Figure
Patient flow through study. Accurately treated is defined as patients with malaria parasites given appropriate malaria drugs
and those without malaria parasites not given malaria drugs
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